Atlas Trials

Boehringer Ingelheim

2,287 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Boehringer Ingelheim

RecordFirmDate
Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck (NCT02254018)Boehringer Ingelheim2002-09-01
Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects (NCT02273544)Boehringer Ingelheim2002-09-01
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) (NCT02244320)Boehringer Ingelheim2002-09-01
Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients (NCT00157235)Boehringer Ingelheim2002-09-01
A Prescription-Event Monitoring (PEM) Study of Tiotropium (NCT02196194)Boehringer Ingelheim2002-09-01
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00274092)Boehringer Ingelheim2002-09-01
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C (NCT02226939)Boehringer Ingelheim2002-09-01
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) (NCT00281567)Boehringer Ingelheim2002-08-01
Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers (NCT02183012)Boehringer Ingelheim2002-08-01
Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects (NCT02254057)Boehringer Ingelheim2002-07-01
Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers (NCT02262559)Boehringer Ingelheim2002-07-01
Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers (NCT02262585)Boehringer Ingelheim2002-07-01
Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers (NCT02187575)Boehringer Ingelheim2002-07-01
Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD (NCT00274040)Boehringer Ingelheim2002-07-01
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT00274638)Boehringer Ingelheim2002-07-01
Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females (NCT02187562)Boehringer Ingelheim2002-07-01
The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy Volunteers (NCT02251119)Boehringer Ingelheim2002-07-01
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis (NCT00042068)Boehringer Ingelheim2002-06-01
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension (NCT02238275)Boehringer Ingelheim2002-06-01
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172482)Boehringer Ingelheim2002-06-01
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice (NCT02172495)Boehringer Ingelheim2002-06-01
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. (NCT00274560)Boehringer Ingelheim2002-05-01
Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers (NCT02251145)Boehringer Ingelheim2002-05-01
Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults (NCT02181972)Boehringer Ingelheim2002-05-01
A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) (NCT00273962)Boehringer Ingelheim2002-05-01
Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers (NCT02180490)Boehringer Ingelheim2002-05-01
A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers (NCT02254538)Boehringer Ingelheim2002-05-01
Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT02172794)Boehringer Ingelheim2002-05-01
Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune® (NCT02191293)Boehringer Ingelheim2002-05-01
Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172456)Boehringer Ingelheim2002-05-01
Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers (NCT02245438)Boehringer Ingelheim2002-05-01
Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects (NCT02254096)Boehringer Ingelheim2002-05-01
Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults (NCT00273988)Boehringer Ingelheim2002-04-01
Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis (NCT02195492)Boehringer Ingelheim2002-04-01
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers (NCT02171442)Boehringer Ingelheim2002-04-01
Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02269189)Boehringer Ingelheim2002-04-01
Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery (NCT02170935)Boehringer Ingelheim2002-04-01
Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers (NCT02261116)Boehringer Ingelheim2002-04-01
Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency (NCT02191163)Boehringer Ingelheim2002-04-01
Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD (NCT00274053)Boehringer Ingelheim2002-04-01
Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BIIB 722 CL and HPβCD in Young Healthy Male Volunteers (NCT02224079)Boehringer Ingelheim2002-04-01
Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis (NCT02195557)Boehringer Ingelheim2002-04-01
Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals (NCT00034866)Boehringer Ingelheim2002-04-01
3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study (NCT00275444)Boehringer Ingelheim2002-03-29
Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects (NCT02211144)Boehringer Ingelheim2002-03-01
Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery (NCT02184273)Boehringer Ingelheim2002-03-01
Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity (NCT00274573)Boehringer Ingelheim2002-03-01
Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects (NCT02170610)Boehringer Ingelheim2002-03-01
Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease (NCT02248168)Boehringer Ingelheim2002-03-01
Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02238119)Boehringer Ingelheim2002-02-01
Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects (NCT02273466)Boehringer Ingelheim2002-02-01
Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects (NCT02170623)Boehringer Ingelheim2002-02-01
Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease (NCT02231255)Boehringer Ingelheim2002-02-01
Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects (NCT02269202)Boehringer Ingelheim2002-02-01
Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers (NCT02181309)Boehringer Ingelheim2002-01-01
Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients (NCT00273975)Boehringer Ingelheim2002-01-01
Spiriva® Assessment of FEV1 (SAFE) (NCT00277264)Boehringer Ingelheim2002-01-01
Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens (NCT02191319)Boehringer Ingelheim2002-01-01
Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects (NCT02170636)Boehringer Ingelheim2002-01-01
Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers (NCT02253823)Boehringer Ingelheim2001-12-01
Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism (NCT00274144)Boehringer Ingelheim2001-12-01
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. (NCT00153101)Boehringer Ingelheim2001-11-01
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection (NCT02226952)Boehringer Ingelheim2001-11-01
Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers (NCT02209831)Boehringer Ingelheim2001-11-01
Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers (NCT02249416)Boehringer Ingelheim2001-11-01
Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers (NCT02180477)Boehringer Ingelheim2001-11-01
Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194322)Boehringer Ingelheim2001-11-01
Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers (NCT02259998)Boehringer Ingelheim2001-10-01
Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02265679)Boehringer Ingelheim2001-10-01
Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease (NCT02209792)Boehringer Ingelheim2001-10-01
Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome (NCT02180516)Boehringer Ingelheim2001-10-01
Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS (NCT02265666)Boehringer Ingelheim2001-10-01
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose (NCT00034840)Boehringer Ingelheim2001-10-01
Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects (NCT02170896)Boehringer Ingelheim2001-10-01
Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring (NCT02242318)Boehringer Ingelheim2001-09-01
Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients (NCT00274001)Boehringer Ingelheim2001-09-01
Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers (NCT02264158)Boehringer Ingelheim2001-09-01
Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study (NCT02195505)Boehringer Ingelheim2001-09-01
Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects (NCT02260076)Boehringer Ingelheim2001-09-01
Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers (NCT02251873)Boehringer Ingelheim2001-09-01
Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00274547)Boehringer Ingelheim2001-09-01
Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal (NCT02260037)Boehringer Ingelheim2001-08-01
Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis (NCT02229747)Boehringer Ingelheim2001-08-01
Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy Subjects (NCT02182037)Boehringer Ingelheim2001-08-01
Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®) (NCT02191241)Boehringer Ingelheim2001-08-01
Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis (NCT02183168)Boehringer Ingelheim2001-07-01
Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke (NCT02251197)Boehringer Ingelheim2001-07-01
Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02194777)Boehringer Ingelheim2001-06-01
Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure (NCT02242331)Boehringer Ingelheim2001-06-01
Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range (NCT02181322)Boehringer Ingelheim2001-06-01
BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis (NCT02209753)Boehringer Ingelheim2001-06-01
Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (NCT02172443)Boehringer Ingelheim2001-06-01
WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients (NCT02182570)Boehringer Ingelheim2001-06-01
WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients (NCT02182557)Boehringer Ingelheim2001-06-01
WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis (NCT02182544)Boehringer Ingelheim2001-06-01
Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI) (NCT02184234)Boehringer Ingelheim2001-06-01
Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect (NCT02268760)Boehringer Ingelheim2001-06-01
Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis (NCT02251210)Boehringer Ingelheim2001-05-01
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis (NCT02184351)Boehringer Ingelheim2001-05-01
Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients (NCT02181946)Boehringer Ingelheim2001-05-01
← Previous Next →

Track Boehringer Ingelheim automatically

Every clearance here is in the API, with alerts when new ones post.